Equity Profile

FMS

Fresenius Medical Care AG

Health CareHealth Care Services$12.6B

Aug4Tue

Pre-Earnings Brief

UpcomingQ2-2023After Close9:00 AM EDT

Company Snapshot

Fresenius Medical Care AG is a leading provider of products and services for individuals with chronic kidney failure. Operating in the Health Care sector, the company plays a crucial role in the healthcare services industry, particularly in dialysis treatment, which is essential for patients who rely on these services for their survival.

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs and generating profit.

$0.50

Revenue

Total revenue reflects the company's ability to grow its business and attract more patients, which is critical for its long-term success.

$4.6B

Wall Street expectations, options signals, track record, and call prep available with Pro.

FMS Q2-2023 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

-6.74%

Avg Stock Reaction

-1.23%

Last Quarter Recap

In Q1 2023, Fresenius Medical Care reported an EPS of $0.17, slightly missing the analyst estimate of $0.18. The stock experienced a minor decline of 0.09% the following day.

Management Promises & Guidance

Focus on improving operational efficiency.
Commitment to enhancing patient care services.
Plans to expand market presence in emerging regions.

Expectations

Wall Street Expectations

Analysts are cautiously optimistic about Fresenius Medical Care's upcoming earnings, with expectations for an EPS of $0.50 and revenue of $4.6 billion. However, the company has struggled with meeting earnings expectations in recent quarters.

Bull Case

If Fresenius can exceed the EPS estimate and show strong revenue growth, it may signal a turnaround in performance and boost investor confidence.

Bear Case

Conversely, if the company misses expectations again, it could raise concerns about its operational challenges and lead to further declines in stock price.

Key Metrics to Watch

EPS

$0.50

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs and generating profit.

Revenue

$4.6B

Total revenue reflects the company's ability to grow its business and attract more patients, which is critical for its long-term success.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS exceed $0.50, indicating a potential recovery in profitability?

A positive EPS surprise could signal improved operational efficiency and restore investor confidence.

What specific revenue growth can we expect, particularly in emerging markets?

Revenue growth in these areas is crucial for long-term sustainability and could indicate the company's ability to expand its market share.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for revenue growth in emerging markets, which could significantly boost overall performance this quarter.

Supporting Evidence

Options pricing suggests a larger move than historical averages, indicating potential for surprise.

The company's focus on operational improvements may yield better-than-expected results.

Recent investments in patient care services could drive higher revenue growth.

Key Risk

If revenue growth exceeds $4.9 billion, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Fresenius can overcome its recent performance issues and deliver growth in a challenging healthcare environment.

Bull Confirmed If

An EPS of $0.53 or higher would confirm the bull case and suggest a strong recovery.

Bear Confirmed If

An EPS below $0.47 would support the bear case, indicating ongoing struggles.

Pre-Earnings Positioning

Options Market

Implied Move

±24.84%

Historical Avg

±2.7%

Pricing rich

The options market is pricing in a significant potential move in either direction, indicating uncertainty among investors ahead of the earnings report.

Options are pricing ±24.8% while FMS has averaged ±2.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

44.1%

Calls (500)P/C Ratio: 1.60Puts (800)

Edge

Institutional Ownership

Smart-money positioning from the most recent 13F filings.

Top holders trimming

Institutional

8.64%

of float

Insider

0.00%

of float

Holders

255

institutions

Top Holders· as of Dec 2025

Pzena Investment Management LLC
14,752,836 sh · $335.9M
2.64%
-0.4%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Fresenius beats expectations, history suggests a potential stock increase of around 2.69%, confirming a positive turnaround narrative.

In-Line / Cautious

An in-line report may lead to muted reactions, as investors weigh management's commentary on future growth.

Miss

A miss could result in a decline, with historical patterns indicating an average drop of about 1.23% following earnings misses.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on operational efficiency improvements.
2Details on revenue growth in emerging markets.
3Management's outlook on patient care services.
4Insights into competitive pressures in the healthcare sector.
5Any changes to long-term growth strategies.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs and generating profit.

$0.50

Revenue

Total revenue reflects the company's ability to grow its business and attract more patients, which is critical for its long-term success.

$4.6B

Wall Street expectations, options signals, track record, and call prep available with Pro.

FMS Q2-2023 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

-6.74%

Avg Stock Reaction

-1.23%

Last Quarter Recap

In Q1 2023, Fresenius Medical Care reported an EPS of $0.17, slightly missing the analyst estimate of $0.18. The stock experienced a minor decline of 0.09% the following day.

Management Promises & Guidance

Focus on improving operational efficiency.
Commitment to enhancing patient care services.
Plans to expand market presence in emerging regions.

Expectations

Wall Street Expectations

Bull Case

If Fresenius can exceed the EPS estimate and show strong revenue growth, it may signal a turnaround in performance and boost investor confidence.

Bear Case

Conversely, if the company misses expectations again, it could raise concerns about its operational challenges and lead to further declines in stock price.

Key Metrics to Watch

EPS

$0.50

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs and generating profit.

Revenue

$4.6B

Total revenue reflects the company's ability to grow its business and attract more patients, which is critical for its long-term success.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS exceed $0.50, indicating a potential recovery in profitability?

A positive EPS surprise could signal improved operational efficiency and restore investor confidence.

What specific revenue growth can we expect, particularly in emerging markets?

Revenue growth in these areas is crucial for long-term sustainability and could indicate the company's ability to expand its market share.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for revenue growth in emerging markets, which could significantly boost overall performance this quarter.

Supporting Evidence

Options pricing suggests a larger move than historical averages, indicating potential for surprise.

The company's focus on operational improvements may yield better-than-expected results.

Recent investments in patient care services could drive higher revenue growth.

Key Risk

If revenue growth exceeds $4.9 billion, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether Fresenius can overcome its recent performance issues and deliver growth in a challenging healthcare environment.

Bull Confirmed If

An EPS of $0.53 or higher would confirm the bull case and suggest a strong recovery.

Bear Confirmed If

An EPS below $0.47 would support the bear case, indicating ongoing struggles.

Pre-Earnings Positioning

Options Market

Implied Move

±24.84%

Historical Avg

±2.7%

Pricing rich

The options market is pricing in a significant potential move in either direction, indicating uncertainty among investors ahead of the earnings report.

Options are pricing ±24.8% while FMS has averaged ±2.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

44.1%

Calls (500)P/C Ratio: 1.60Puts (800)

Edge

Institutional Ownership

Smart-money positioning from the most recent 13F filings.

Top holders trimming

Institutional

8.64%

of float

Insider

0.00%

of float

Holders

255

institutions

Top Holders· as of Dec 2025

Pzena Investment Management LLC
14,752,836 sh · $335.9M
2.64%
-0.4%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Fresenius beats expectations, history suggests a potential stock increase of around 2.69%, confirming a positive turnaround narrative.

In-Line / Cautious

An in-line report may lead to muted reactions, as investors weigh management's commentary on future growth.

Miss

A miss could result in a decline, with historical patterns indicating an average drop of about 1.23% following earnings misses.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on operational efficiency improvements.
2Details on revenue growth in emerging markets.
3Management's outlook on patient care services.
4Insights into competitive pressures in the healthcare sector.
5Any changes to long-term growth strategies.